These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 28515153)

  • 21. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.
    Sakan H; Nakatani K; Asai O; Imura A; Tanaka T; Yoshimoto S; Iwamoto N; Kurumatani N; Iwano M; Nabeshima Y; Konishi N; Saito Y
    PLoS One; 2014; 9(1):e86301. PubMed ID: 24466013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
    J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The suppressive effect of soluble Klotho on fibroblastic growth factor 23 synthesis in UMR-106 osteoblast-like cells.
    Ma L; Gao M; Wu L; Zhao X; Mao H; Xing C
    Cell Biol Int; 2018 Sep; 42(9):1270-1274. PubMed ID: 29851201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene.
    Han X; Ross J; Kolumam G; Pi M; Sonoda J; King G; Quarles LD
    J Am Soc Nephrol; 2018 Jan; 29(1):69-80. PubMed ID: 28993502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A decreased soluble Klotho level with normal eGFR, FGF23, serum phosphate, and FEP in an ADPKD patient with enlarged kidneys due to multiple cysts.
    Kanai T; Shiizaki K; Betsui H; Aoyagi J; Yamagata T
    CEN Case Rep; 2018 Nov; 7(2):259-263. PubMed ID: 29767399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.
    Saji F; Shigematsu T; Sakaguchi T; Ohya M; Orita H; Maeda Y; Ooura M; Mima T; Negi S
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D; Friedlander G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphate-sensing and regulatory mechanism of FGF23 production.
    Takashi Y; Fukumoto S
    J Endocrinol Invest; 2020 Jul; 43(7):877-883. PubMed ID: 32140858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGFR3 and FGFR4 do not mediate renal effects of FGF23.
    Liu S; Vierthaler L; Tang W; Zhou J; Quarles LD
    J Am Soc Nephrol; 2008 Dec; 19(12):2342-50. PubMed ID: 18753255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA-SNHG29 inhibits vascular smooth muscle cell calcification by downregulating miR-200b-3p to activate the α-Klotho/FGFR1/FGF23 axis.
    Huang C; Zhan JF; Chen YX; Xu CY; Chen Y
    Cytokine; 2020 Dec; 136():155243. PubMed ID: 32818704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant FGF23 prevents the progression of chronic kidney disease but aggravates renal osteodystrophy in uremic rats.
    Kusano K; Saito H; Segawa H; Fukushima N; Miyamoto K
    J Nutr Sci Vitaminol (Tokyo); 2009 Apr; 55(2):99-105. PubMed ID: 19436134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of α-Klotho Expression by Dietary Phosphate During Growth Periods.
    Fukuda-Tatano S; Yamamoto H; Nakahashi O; Yoshikawa R; Hayashi M; Kishimoto M; Imi Y; Yamanaka-Okumura H; Ohnishi K; Masuda M; Taketani Y
    Calcif Tissue Int; 2019 Jun; 104(6):667-678. PubMed ID: 30671592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Updates on rickets and osteomalacia: various roles of Klotho and FGF23 in vivo ].
    Imura A
    Clin Calcium; 2013 Oct; 23(10):1476-82. PubMed ID: 24076646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleiotropic Actions of FGF23.
    Erben RG
    Toxicol Pathol; 2017 Oct; 45(7):904-910. PubMed ID: 29096595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.